tirzepatide surmount 4 ESC 2025: post-hoc SURMOUNT-5 data affirms tirzepatide's lead in CVD risk reduction SURMOUNT‐1 study design. This is

GLP1-GO is a privacy-first tracker for Mounjaro, Ozempic, Wegovy, Zepbound, Saxenda, and other GLP-1 weight-loss medications (including tirzepatide and semaglutide)

Ruddick JP, Evans AK, Nutt DJ, Lightman SL, Rook GA, Lowry CA

It highlights the limits of passive surveillance and emphasizes cautious, evidence-based practice

50% of employer clients reversed metabolic syndrome through early intervention that helps reduce the risk of costly chronic conditions

GLP-1RAs have pleiotropic effects: they improve neurogenesis, reduce apoptosis, protect neurons from oxidative stress, and reduce neuroinflammation in various neurological conditions, and it is these beneficial effects that can be used in aging-related diseases, mainly AD and PD